Open access
Sep 2026
Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis
S. Gupta, M. Seshadri, R. Dandekar et al.
· medRxiv · 0 citations